| Literature DB >> 24800227 |
Zdeněk Fík1, Jaromír Astl2, Michal Zábrodský3, Petr Lukeš3, Ilja Merunka4, Jan Betka3, Martin Chovanec3.
Abstract
Minimally invasive video-assisted thyroidectomy (MIVAT) and minimally invasive nonendoscopic thyroidectomy (MINET) represent well accepted and reproducible techniques developed with the main goal to improve cosmetic outcome, accelerate healing, and increase patient's comfort following thyroid surgery. Between 2007 and 2011, a prospective nonrandomized study of patients undergoing minimally invasive thyroid surgery was performed to compare advantages and disadvantages of the two different techniques. There were no significant differences in the length of incision to perform surgical procedures. Mean duration of hemithyroidectomy was comparable in both groups, but it was more time consuming to perform total thyroidectomy by MIVAT. There were more patients undergoing MIVAT procedures without active drainage in the postoperative course and we also could see a trend for less pain in the same group. This was paralleled by statistically significant decreased administration of both opiates and nonopiate analgesics. We encountered two cases of recurrent laryngeal nerve palsies in the MIVAT group only. MIVAT and MINET represent safe and feasible alternative to conventional thyroid surgery in selected cases and this prospective study has shown minimal differences between these two techniques.Entities:
Mesh:
Year: 2014 PMID: 24800227 PMCID: PMC3996987 DOI: 10.1155/2014/450170
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Patient characteristics.
| MIVAT | MINET | |
|---|---|---|
|
| 60 | 71 |
| TTE | 40 | 41 |
| HTE | 20* | 30 |
| Age (years) | 40 ± 14 (17–75) | 37 ± 14 (10–68) |
| Gender (males/females) | 6/54 | 6/66 |
MIVAT: minimally invasive video-assisted thyroidectomy; MINET: minimally invasive nonendoscopic thyroidectomy; TTE: total thyroidectomy; HTE: hemithyroidectomy; *2 cases of isthmectomies were analyzed together with hemithyroidectomies.
Volume of thyroid lobe and nodule size as assessed on preoperative ultrasonography.
| MIVAT | MINET | |
|---|---|---|
| Nodule size | 20 ± 11 (3–49) mm | 21 ± 10 (3–50) mm |
| Volume of the lobe | 12 ± 7 (3–56) mL | 12 ± 7 (3–35) mL |
MIVAT: minimally invasive video-assisted thyroidectomy; MINET: minimally invasive nonendoscopic thyroidectomy.
Treated thyroid gland pathologies.
| Pathology treated | MIVAT | MINET |
|---|---|---|
| Benign follicular neoplasm | 36 | 42 |
| WDTC | 17 | 18 |
| T1 | 13 | 12 |
| T2 | 1 | 4 |
| T3 | 3 | 2 |
| Thyreotoxicosis | 7 | 10 |
| GBD | 5 | 6 |
| Toxic adenoma | 1 | |
| Amiodaron induced toxicosis | 1 | |
| Nootropil induced toxicosis | 1 | |
| Plummer's disease | 3 |
MIVAT: minimally invasive video-assisted thyroidectomy, MINET: minimally invasive non-endoscopic thyroidectomy, WDTC: well-differentiated thyroid cancer, T1–T3: T-staging according 7th edition of TNM classification of malignant tumors, GBD: Graves-Basedow disease.
Size of incision, duration of surgery, and postoperative blood loss.
| MIVAT-HTE | MINET-HTE |
| MIVAT-TTE | MINET-TTE |
| |
|---|---|---|---|---|---|---|
| Length of incision | 19 ± 6 (11–30) mm | 23 ± 5 (15–30) mm | 0.06 | 25 ± 5 (15–30) mm | 26 ± 5 (15–30) mm | 0.30 |
| Duration of surgery | 77 ± 24 (47–150) min | 71 ± 15 (44–100) min | 0.98 | 108 ± 33 (60–240) min | 96 ± 18 (62–130) min | 0.05 |
| Blood loss* | 42 ± 39 (10–170) mL | 34 ± 19 (10–70) mL | 0.49 | 61 ± 32 (14–120) mL | 63 ± 25 (20–140) mL | 0.83 |
MIVAT: minimally invasive video-assisted thyroidectomy; MINET: minimally invasive nonendoscopic thyroidectomy; *measured from the bottle of the active drainage.
Postoperative pain and analgesics consumption.
| MIVAT-HTE | MINET-HTE |
| MIVAT-TTE | MINET-TTE |
| |
|---|---|---|---|---|---|---|
| Postoperative pain | ||||||
| VAS1 h postoperatively | 1.7 ± 1.4 (0–8) | 1.8 ± 1.7 (0–6) | 0.96 | 1.9 ± 1.5 (0–5) | 2.4 ± 2 (0–6) | 0.18 |
| VAS6 h postoperatively | 1.5 ± 1.5 (0–5) | 1.7 ± 1.3 (0–5) | 0.57 | 1.2 ± 1.1 (0–5) | 1.2 ± 1.4 (0–5) | 0.66 |
| VAS12 h postoperatively | 0.3 ± 0.6 (0–2) | 1.5 ± 0.8 (0–5) | 0.49 | 0.6 ± 1 (0–4) | 1.1 ± 1.6 (0–5) | 0.07 |
| Analgesics consumption | ||||||
| Opiates* | 13 | 23 | 0.37 | 26 | 34 | 0.07 |
| Nonopiates** | 3 | 6 | 0.65 | 3 | 14 | <0.01 |
| Without analgesics postoperatively | 5 | 5 | 0.47 | 13 | 6 | 0.06 |
| Without analgesics since 1st postoperative day | 17 | 24 | 0.65 | 36 | 26 | 0.01 |
MIVAT: minimally invasive video-assisted thyroidectomy; MINET: minimally invasive nonendoscopic thyroidectomy; VAS: 10 grade visual analogue scale; *opiates administered at the day of surgery; **nonopiates administered since the surgery.